Skip to main content
SpringerLink
Log in

Hemibodies beim multiplen Myelom

"Mix and Match" als nebenwirkungsarmes Therapieprinzip

  • Allgemeine Onkologie
  • Published:
Im Fokus Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2

© Cherry Biolabs GmbH

Author information

Authors and Affiliations

  1. Freie Medizinjournalistin, Dresden, Deutschland

    Sabrina Kempe

Authors
  1. Sabrina Kempe
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kempe, S. Hemibodies beim multiplen Myelom. Im Fokus Onkologie 26, 21–23 (2023). https://doi.org/10.1007/s15015-023-3254-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15015-023-3254-7

Search

Navigation